In the high-stakes world of biotechnology acquisitions, the value of a company is more than just a dollar amount—it’s a complex equation that combines intrinsic value, strategic opportunity, and the potential for long-term success. The ongoing saga of Sunoco’s proposed takeover of gas-station owner Parkland Corp. is a prime example of this intricate dance. Engine […]